ID   Me14362
AC   CVCL_HF03
SY   Me#14362
DR   cancercelllines; CVCL_HF03
DR   Wikidata; Q54904918
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RX   PubMed=22553342;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DOI=10.13130/grazia-giulia_phd2016-02-18).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
RX   DOI=10.13130/grazia-giulia_phd2016-02-18;
RA   Grazia G.;
RT   "Co-targeting of oncogenic and death receptors pathways in human
RT   melanoma: pre-clinical rationale for a pro-apoptotic and anti-angiogenic
RT   strategy.";
RL   Thesis PhD (2015); Universita degli studi di Milano; Milano; Italy.
//
RX   PubMed=22553342; DOI=10.1158/1078-0432.CCR-11-2232; PMCID=PMC3426233;
RA   Tassi E., Zanon M., Vegetti C., Molla A., Bersani I., Perotti V.,
RA   Pennati M., Zaffaroni N., Milella M., Ferrone S., Carlo-Stella C.,
RA   Gianni A.M., Mortarini R., Anichini A.;
RT   "Role of Apollon in human melanoma resistance to antitumor agents that
RT   activate the intrinsic or the extrinsic apoptosis pathways.";
RL   Clin. Cancer Res. 18:3316-3327(2012).
//